Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Paclitaxel + TORL-1-23 |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Paclitaxel | Taxol | 7-Epipaclitaxel | Antimicrotubule Agent 14 BCL2 Family Inhibitor 6 | Taxol (paclitaxel) binds to tubulin to inhibit microtubule disassembly, which results in decreased cell division, and also binds to the anti-apoptotic factor Bcl-2, promoting apoptosis (NCI Drug Dictionary). |
| TORL-1-23 | TORL 1-23|TORL1-23|CLDN6-23-ADC|TORL123 | CLDN6 Antibody 10 | TORL-1-23 is an antibody-drug conjugate (ADC) comprising a monoclonal antibody targeting CLDN6 linked to monomethyl auristatin E (MMAE), which potentially inhibits growth of CLDN6-expressing tumors (PMID: 36884217). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07322094 | Phase Ib/II | Carboplatin + Paclitaxel + TORL-1-23 Paclitaxel + TORL-1-23 Carboplatin + TORL-1-23 | CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer | Recruiting | USA | 0 |